Pillstats
Rx only · Emulsion · Ophthalmic

Cyclosporine

Brands: Restasis · Restasis Multidose · Verkazia · Cyclosporine

13 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
13 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers13 labelers
Packages27
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 17 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$3.00$5.99$8.99$11.99Dec 2025Apr 2026Jul 2026
$8.719
Latest avg · Jul 22, 2026
-16%
Since Dec 17, 2025
13
Active US suppliers
22%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

53K106K159K212K2025 Q12025 Q22025 Q32025 Q42026 Q1
175K
Rx · 2026 Q1
5.8M
Units dispensed
+9%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it13 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Allergan, Inc.unknown4SUPPLYING
Harrow Eye, LLCunknown2SUPPLYING
Upsher-Smith Laboratories, LLCunknown2SUPPLYING
Mylan Pharmaceuticals Inc.unknown2SUPPLYING
KVK-TECH, Inc.unknown2SUPPLYING
Lupin Pharmaceuticals,Inc.unknown2SUPPLYING
Santen Incorporatedunknown2SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown2SUPPLYING
Apotex Corp.unknown2SUPPLYING
Amneal Pharmaceuticals LLCunknown2SUPPLYING
Saptalis Pharmaceuticals, LLC.unknown2SUPPLYING
Devatis, Inc.unknown2SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.